CELL INTELLIGENCE · 肿瘤细胞治疗研究

探索肝细胞癌中 Glypican-3 靶向 CAR-NK 治疗与潜在治疗耐药

Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma.

肝细胞癌（HCC）是原发性肝癌中最常见的类型，也是全球癌症相关死亡的第二大原因。